Canadian enforcer enters into rare abuse settlement
Canada’s Competition Bureau has approved a rare abuse of dominance settlement after a nuclear medicine company agreed to remove exclusivity clauses from its contracts with new customers.
To read more
Subscribe to Global Competition Review
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the Global Competition Review experts.